Articles & guides — page 6
125 cited, vendor-independent pieces on the questions people actually ask — reconstitution and handling, half-lives, compound comparisons, and how to track a protocol. Research and education only; never dosing advice, never sourcing.
125 articles
What is MK-677 (Ibutamoren)?
MK-677 (Ibutamoren) explained: the oral ghrelin-mimetic that raised GH and IGF-1 in human trials, and the honest catch on appetite, edema and failed endpoints.
Human clinical dataCompound overviews5 minWhat is GHRP-6?
GHRP-6 explained: a ghrelin-mimetic hexapeptide that triggers a growth-hormone pulse and a sharp hunger signal, with human GH data but mostly preclinical uses.
Human clinical dataCompound overviews4 minWhat is GHRP-2 (Pralmorelin)?
GHRP-2 (Pralmorelin) explained: a ghrelin-mimetic that provokes a growth-hormone pulse — the only GHRP approved anywhere, as a diagnostic test in Japan.
Human clinical dataCompound overviews6 minWhat is PT-141 (Bremelanotide)?
PT-141 (bremelanotide) explained from the primary literature: its melanocortin (MC4R) brain mechanism, the phase-3 HSDD trials, and its FDA-approved status.
Approved medicineCompound overviews6 minWhat is Melanotan II?
Melanotan II explained honestly: how this unapproved melanocortin agonist works, and the melanoma, priapism, and nausea signals documented in case reports.
PreclinicalCompound overviews7 minWhat is Cagrilintide?
Cagrilintide explained with the human data: the once-weekly amylin analog, how it curbs appetite, and what CagriSema's REDEFINE phase-3 trials showed in obesity and type 2 diabetes.
Human clinical dataCompound overviews5 minWhat is AOD-9604?
AOD-9604 explained honestly: the modified growth-hormone fragment marketed for fat loss, its beta-3 lipolysis mechanism in mice, and why its largest human obesity trial missed its primary endpoint.
Human clinical dataCompound overviews5 minWhat is HGH Fragment 176-191?
HGH Fragment 176-191 explained honestly: the tail-end piece of growth hormone marketed as a fat-loss peptide, its lipolysis mechanism in animals, and why the human evidence is essentially absent.
PreclinicalCompound overviews5 minWhat is tesofensine?
Tesofensine explained with the trial data: a triple monoamine reuptake inhibitor studied for obesity, the 24-week phase 2 results (up to 10.6% weight loss), and its unapproved status.
Human clinical dataCompound overviews4 minWhat is SLU-PP-332?
SLU-PP-332 explained with the science: a synthetic pan-ERR agonist studied as an "exercise mimetic" — what it did in mice for metabolism and fitness, and why there is no human data.
PreclinicalCompound overviews4 minWhat is 5-amino-1MQ?
5-amino-1MQ explained with the science: a small-molecule NNMT inhibitor that reversed diet-induced obesity in mice by boosting fat-cell metabolism — and why there is no human data.
PreclinicalCompound overviews5 minWhat is bimagrumab?
Bimagrumab explained: the anti-ActRII monoclonal antibody that builds muscle while stripping fat, its phase-2 trial results, why it is being paired with GLP-1 drugs, and its status today.
Human clinical dataZyra Track is a research and educational utility. Nothing on this page is medical advice, a dosing recommendation, or an endorsement of any compound. We never sell or source compounds and refuse sourcing questions. Consult a qualified clinician for decisions about your health.